GLP-1 receptor agonists and pancreatic safety concerns in type 2 diabetic patients: data from cardiovascular outcome trials

Shu-Ting YANG

Physician

An endocrinologist passionate about artificial intelligence and diabetes, focusing on applying machine learning and bioinformatics to diabetes heterogeneity research.